Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-30 Sale | 2022-10-04 5:06 pm | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 4,458 | $4.0028 | $17,844 | 135,792 (Direct) | View |
| 2021-06-02 Purchase | 2021-06-04 5:00 pm | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 250 | $20 | $5,000 | 500,588 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-31 Tax Withholding | 2023-04-04 5:04 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 4,103 | $3.9 | 188,244 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:14 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 150,400 | $0 | 282,347 (Direct) | View |
| 2022-09-30 Tax Withholding | 2023-01-13 5:47 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 5,382 | $4.25 | 134,868 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 7:26 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 2,921 | $3.1 | 137,329 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 6:15 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 140,000 | $0 | 140,250 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 6:30 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2021-04-20 Option Award | 2021-06-04 5:00 pm | N/A 2031-04-20 | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 500,338 | $0 | 500,588 (Direct) | View |
Ownership | 2021-05-27 8:34 pm | N/A 2031-04-20 | Centessa Pharmaceuticals plc | CNTA | Templeman Thomas Chief Technology Officer | 0 | $0 | 500,338 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 5:48 pm | N/A 2030-10-04 | Nuvation Bio Inc. | NUVB | Templeman Thomas SVP, Pharmaceutical Ops | 797,870 | $0 | 797,870 (Direct) | View |
Ownership | 2021-02-12 5:33 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Templeman Thomas SVP, Pharmaceutical Ops | 0 | $0 | 0 (Direct) | View |